Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Jesus

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|November 15, 2017
Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous primingEdna Soares, Sandra Jesus, Olga Borges
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 27, 2018
Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigenEdna Soares, Sandra Jesus, Olga Borges
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal VaccinationSandra Jesus, Edna Soares, Olga Borges
Methods in Enzymology|May 10, 2012
Chitosan-based nanoparticles as a hepatitis B antigen delivery systemFilipa Lebre, Dulce Bento, Sandra Jesus, et al.
Molecular Pharmaceutics|November 22, 2017
Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 ProductionSandra Jesus, Edna Soares, Gerrit Borchard, et al.
Nanomedicine (London, England)|September 5, 2017
Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigenSandra Jesus, Edna Soares, Gerrit Borchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 6, 2018
Exosomes as adjuvants for the recombinant hepatitis B antigen: First reportSandra Jesus, Edna Soares, Maria Teresa Cruz, et al.
International Journal of Pharmaceutics|March 16, 2016
Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticlesSandra Jesus, Edna Soares, João Costa, et al.
Pharmaceutics|February 13, 2019
Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine AdjuvantDulce Bento, Sandra Jesus, Filipa Lebre, et al.
Chemical Research in Toxicology|March 7, 2020
Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the ImmunotoxicityMariana Colaço, Ana P Marques, Sandra Jesus, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|November 15, 2017
Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous primingEdna Soares, Sandra Jesus, Olga Borges
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 27, 2018
Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigenEdna Soares, Sandra Jesus, Olga Borges
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal VaccinationSandra Jesus, Edna Soares, Olga Borges
Methods in Enzymology|May 10, 2012
Chitosan-based nanoparticles as a hepatitis B antigen delivery systemFilipa Lebre, Dulce Bento, Sandra Jesus, et al.
Molecular Pharmaceutics|November 22, 2017
Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 ProductionSandra Jesus, Edna Soares, Gerrit Borchard, et al.
Nanomedicine (London, England)|September 5, 2017
Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigenSandra Jesus, Edna Soares, Gerrit Borchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 6, 2018
Exosomes as adjuvants for the recombinant hepatitis B antigen: First reportSandra Jesus, Edna Soares, Maria Teresa Cruz, et al.
International Journal of Pharmaceutics|March 16, 2016
Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticlesSandra Jesus, Edna Soares, João Costa, et al.
Pharmaceutics|February 13, 2019
Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine AdjuvantDulce Bento, Sandra Jesus, Filipa Lebre, et al.
Chemical Research in Toxicology|March 7, 2020
Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the ImmunotoxicityMariana Colaço, Ana P Marques, Sandra Jesus, et al.
Pageof 3